Versant Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50
Closed -$401 1883
2023
Q4
$401 Hold
50
﹤0.01% 1726
2023
Q3
$411 Hold
50
﹤0.01% 1731
2023
Q2
$400 Hold
50
﹤0.01% 1882
2023
Q1
$405 Hold
50
﹤0.01% 1617
2022
Q4
$314 Hold
50
﹤0.01% 1521
2022
Q3
$0 Hold
50
﹤0.01% 1427
2022
Q2
$0 Buy
+50
New +$699 ﹤0.01% 1444
2019
Q2
Sell
-21
Closed 1412
2019
Q1
$0 Hold
21
﹤0.01% 1562
2018
Q4
$0 Hold
21
﹤0.01% 1477
2018
Q3
$0 Hold
21
﹤0.01% 1516
2018
Q2
$0 Hold
21
﹤0.01% 1508
2018
Q1
$0 Hold
21
﹤0.01% 1488
2017
Q4
$0 Hold
21
﹤0.01% 1529
2017
Q3
$0 Hold
21
﹤0.01% 1445
2017
Q2
$0 Hold
21
﹤0.01% 1438
2017
Q1
$0 Hold
21
﹤0.01% 1435
2016
Q4
$0 Hold
21
﹤0.01% 1389
2016
Q3
$0 Hold
21
﹤0.01% 1376
2016
Q2
$0 Hold
21
﹤0.01% 1340
2016
Q1
$0 Hold
21
﹤0.01% 1335
2015
Q4
$2K Buy
+21
New +$2.36K ﹤0.01% 1111

Other funds holding BHC

Versant Capital Management's BHC Position: Q1 2024 in Review

Versant Capital Management sold out of Bausch Health (BHC) in Q1 2024, closing a stake of 50 shares — an estimated $401 sold.

Versant Capital Management first reported a position in BHC in Q4 2015 and held it in 21 quarters. The position peaked at $2K in Q4 2015. 237 funds tracked by Wall St. Rank hold BHC as of Q1 2024.

  • Versant Capital Management reported no remaining Bausch Health position as of Q1 2024 after selling out during the quarter.
  • Versant Capital Management sold 50 Bausch Health shares in Q1 2024, an estimated $401.
  • Versant Capital Management first reported a position in Bausch Health in Q4 2015 and held it in 21 quarters.
  • Versant Capital Management's Bausch Health position peaked at $2K in Q4 2015.
  • 237 funds tracked by Wall St. Rank held Bausch Health as of Q1 2024.

Based on Versant Capital Management's 13F filing for Q1 2024, filed 3 Apr 2024.